Journal of Isfahan Medical School

Journal of Isfahan Medical School

Association Between Cesarean Scar Defect Morphology and Gynecologic Symptoms: A Two-Center Cross-Sectional Study

Document Type : Original Article (s)

Authors
1 Clinical Research Development Unit, Firoozabadi Hospital, Department of Radiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
2 Department of Obstetrics and Gynecology, Iran University of Medical Sciences, Tehran, Iran
Abstract
Background: Cesarean scar defect (CSD), also known as isthmocele or uterine niche, may be associated with abnormal uterine bleeding (AUB), postmenstrual spotting, dysmenorrhea, and dyspareunia. However, the relationship between sonographic CSD morphology and gynecologic symptoms remains inconsistent. This study evaluated the association between CSD dimensions and gynecologic symptoms in women undergoing transvaginal ultrasonography.
Methods: This two-center cross-sectional analytical study included women with confirmed CSD referred to Firoozabadi and Akbarabadi Hospitals, Tehran, Iran, from March 2025 to March 2026. CSD length, CSD depth, residual myometrial thickness (RMT), and adjacent myometrial thickness were measured by transvaginal ultrasonography. Symptoms, including irregular menstruation, postmenstrual spotting/AUB, severe AUB, dysmenorrhea, and dyspareunia, were recorded as binary outcomes. Statistical comparisons were performed using appropriate parametric or nonparametric tests, with P <0.05 considered statistically significant.
Findings: Among 207 women included in the final analysis, the mean age was 33.1±5.2 years. The mean CSD length, CSD depth, and RMT were 4.30±1.26 mm, 5.93±2.23 mm, and 4.38±2.04 mm, respectively. Postmenstrual spotting/AUB was reported in 78 women (37.7%), irregular menstruation in 71 (34.3%), severe AUB in 41 (19.8%), dysmenorrhea in 41 (19.8%), and dyspareunia in 35 (16.9%). RMT was significantly associated with irregular menstruation (P: 0.038), and CSD depth was significantly associated with postmenstrual spotting/AUB (P: 0.046). No significant associations were observed between measured CSD parameters and severe AUB, dysmenorrhea, or dyspareunia.
Conclusion: CSD depth and RMT may be more relevant to bleeding-related symptoms than pain-related symptoms. CSD morphology should be interpreted alongside clinical symptoms and other gynecologic factors.

Highlights

Hasanali Kheybari: Google Scholar

Farahnaz Farzaneh: Google Scholar

 Ensieh Farhidzadeh : Google Scholar

Zeinab Safarpour lima: Google Scholar

Ayda Roostaee: Google Scholar

Keywords
Subjects

1.     Klein Meuleman SJM, Murji A, van den Bosch T, Donnez O, Grimbizis G, Saridogan E, et al. Definition and Criteria for Diagnosing Cesarean Scar Disorder. JAMA Netw Open 2023; 6(3): e235321.
2.     Naji O, Abdallah Y, Bij De Vaate AJ, Smith A, Pexsters A, Stalder C, et al. Standardized approach for imaging and measuring Cesarean section scars using ultrasonography. Ultrasound Obstet Gynecol 2012; 39(3): 252-9.
3.     Verberkt C, Jordans IPM, Van den Bosch T, Timmerman D, Bourne T, de Leeuw RA, et al. How to perform standardized sonographic examination of uterine niche in non-pregnant women. Ultrasound Obstet Gynecol 2022; 60(3): 420-4.
4.     Vigashini A, Pallavee P. Prevalence and risk factors of sonographically detected cesarean scar defects: a review. SBV Journal of Basic, Clinical and Applied Health Science 2024; 7(3): 123-7.
5.     Antila RM, Mäenpää JU, Huhtala HS, Tomás EI, Staff SM. Association of cesarean scar defect with abnormal uterine bleeding: The results of a prospective study. Eur J Obstet Gynecol Reprod Biol 2020; 244: 134-40.
6.     Armstrong F, Mulligan K, Dermott RM, Bartels HC, Carroll S, Robson M, et al. Cesarean scar niche: An evolving concern in clinical practice. Int J Gynaecol Obstet 2023; 161(2): 356-66.
7.     Murji A, Sanders AP, Monteiro I, Haiderbhai S, Matelski J, Walsh C, et al. Cesarean scar defects and abnormal uterine bleeding: a systematic review and meta-analysis. Fertil Steril 2022; 118(4): 758-66.
8.     Xu XJ, Jia JX, Sang ZQ, Li L. Association of caesarean scar defect with risk of abnormal uterine bleeding: results from meta-analysis. BMC Womens Health 2024; 24(1): 432.
9.     Tsuji S, Nobuta Y, Hanada T, Takebayashi A, Inatomi A, Takahashi A, et al. Prevalence, definition, and etiology of cesarean scar defect and treatment of cesarean scar disorder: A narrative review. Reprod Med Biol 2023; 22(1): e12532.
10.  Bij de Vaate AJ, Brölmann HA, van der Voet LF, van der Slikke JW, Veersema S, Huirne JA. Ultrasound evaluation of the Cesarean scar: relation between a niche and postmenstrual spotting. Ultrasound Obstet Gynecol 2011; 37(1): 93-9.
11.  van der Voet LF, Bij de Vaate AM, Veersema S, Brölmann HA, Huirne JA. Long-term complications of caesarean section. The niche in the scar: a prospective cohort study on niche prevalence and its relation to abnormal uterine bleeding. BJOG 2014; 121(2): 236-44.
12.  Wang CB, Chiu WW, Lee CY, Sun YL, Lin YH, Tseng CJ. Cesarean scar defect: correlation between Cesarean section number, defect size, clinical symptoms and uterine position. Ultrasound Obstet Gynecol 2009; 34(1): 85-9.
13.  Wang J, Pang Q, Wei W, Cheng L, Huang F, Cao Y, et al. Definition of large niche after Cesarean section based on prediction of postmenstrual spotting: Chinese cohort study in non-pregnant women. Ultrasound Obstet Gynecol 2022; 59(4): 450-6.
14.  Yao M, Wang W, Zhou J, Sun M, Zhu J, Chen P, et al. Cesarean section scar diverticulum evaluation by saline contrast-enhanced magnetic resonance imaging: The relationship between variable parameters and longer menstrual bleeding. J Obstet Gynaecol Res 2017; 43(4): 696-704.
15.  Bandry KW, Abou-Taleb H, Seifeldein GS, Taha MG, Qenawy OK. Prediction of the relationship of cesarean section scar niche and postmenstrual spotting: is there any relation? Egypt J Radiol Nucl Med 2022; 53(1): 24.
Allameh Z, Rouholamin S, Rasti S, Adibi A, Foroughi Z, Goharian M, et al. A transvaginal ultrasound-based diagnostic calculator for uterus post-cesarean scar defect. BMC Womens Health 2023; 23(1): 558
Volume 44, Issue 872
4th Week, September
September and October 2026
Pages 1340-1347

  • Receive Date 01 August 2026
  • Accept Date 17 August 2026